Vitiello A - Search Results

1

Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome.

Wentworth PA, Sette A, Celis E, Sidney J, Southwood S, Crimi C, Stitely S, Keogh E, Wong NC, Livingston B, Alazard D, Vitiello A, Grey HM, Chisari FV, Chesnut RW, Fikes J. Wentworth PA, et al. Among authors: vitiello a. Int Immunol. 1996 May;8(5):651-9. doi: 10.1093/intimm/8.5.651. Int Immunol. 1996. PMID: 8671652

2

Random association between the peptide repertoire of A2.1 class I and several different DR class II molecules.

Sette A, Vitiello A, Farness P, Furze J, Sidney J, Claverie JM, Grey HM, Chesnut R. Sette A, et al. Among authors: vitiello a. J Immunol. 1991 Dec 1;147(11):3893-900. J Immunol. 1991. PMID: 1658152

3

Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex.

Vitiello A, Marchesini D, Furze J, Sherman LA, Chesnut RW. Vitiello A, et al. J Exp Med. 1991 Apr 1;173(4):1007-15. doi: 10.1084/jem.173.4.1007. J Exp Med. 1991. PMID: 1706750 Free PMC article.

4

The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.

Sette A, Vitiello A, Reherman B, Fowler P, Nayersina R, Kast WM, Melief CJ, Oseroff C, Yuan L, Ruppert J, Sidney J, del Guercio MF, Southwood S, Kubo RT, Chesnut RW, Grey HM, Chisari FV. Sette A, et al. Among authors: vitiello a. J Immunol. 1994 Dec 15;153(12):5586-92. J Immunol. 1994. PMID: 7527444

5

Class I MHC-peptide interactions: structural requirements and functional implications.

Grey HM, Ruppert J, Vitiello A, Sidney J, Kast WM, Kubo RT, Sette A. Grey HM, et al. Among authors: vitiello a. Cancer Surv. 1995;22:37-49. Cancer Surv. 1995. PMID: 7536628 Review.

6

HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.

Nayersina R, Fowler P, Guilhot S, Missale G, Cerny A, Schlicht HJ, Vitiello A, Chesnut R, Person JL, Redeker AG, Chisari FV. Nayersina R, et al. Among authors: vitiello a. J Immunol. 1993 May 15;150(10):4659-71. J Immunol. 1993. PMID: 7683326

7

Differences and similarities in the A2.1-restricted cytotoxic T cell repertoire in humans and human leukocyte antigen-transgenic mice.

Wentworth PA, Vitiello A, Sidney J, Keogh E, Chesnut RW, Grey H, Sette A. Wentworth PA, et al. Among authors: vitiello a. Eur J Immunol. 1996 Jan;26(1):97-101. doi: 10.1002/eji.1830260115. Eur J Immunol. 1996. PMID: 8566090

8

Immunodominance analysis of CTL responses to influenza PR8 virus reveals two new dominant and subdominant Kb-restricted epitopes.

Vitiello A, Yuan L, Chesnut RW, Sidney J, Southwood S, Farness P, Jackson MR, Peterson PA, Sette A. Vitiello A, et al. J Immunol. 1996 Dec 15;157(12):5555-62. J Immunol. 1996. PMID: 8955206

9

Comparison of cytotoxic T lymphocyte responses induced by peptide or DNA immunization: implications on immunogenicity and immunodominance.

Vitiello A, Sette A, Yuan L, Farness P, Southwood S, Sidney J, Chesnut RW, Grey HM, Livingston B. Vitiello A, et al. Eur J Immunol. 1997 Mar;27(3):671-8. doi: 10.1002/eji.1830270315. Eur J Immunol. 1997. PMID: 9079808

10

Design and testing of peptide-based cytotoxic T-cell-mediated immunotherapeutics to treat infectious diseases and cancer.

Chesnut RW, Sette A, Celis E, Wentworth P, Kubo RT, Alexander J, Ishioka G, Vitiello A, Grey HM. Chesnut RW, et al. Among authors: vitiello a. Pharm Biotechnol. 1995;6:847-74. doi: 10.1007/978-1-4615-1823-5_38. Pharm Biotechnol. 1995. PMID: 7551252 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

311 results

Search Page

Filters